InMode Confirms Receipt of Unsolicited Acquisition Proposal from Steel Partners

InMode Acknowledges Acquisition Proposal from Steel Partners

On July 10, 2026, InMode Ltd., a prominent name in medical technology, confirmed that its Board of Directors has received an unsolicited acquisition proposal from Steel Partners Holdings L.P. This revelation was disclosed in a public statement, indicating the Company’s commitment to transparency as it navigates the complexities of potential corporate transactions.

The proposal, dated July 9, suggests a strategic interest by Steel Partners in acquiring InMode, prompting a series of evaluations by the Company. As part of the process, InMode has constituted a Special Committee, strictly composed of independent directors. This committee is charged with the responsibility of reviewing the acquisition proposal with utmost diligence and in alignment with their fiduciary obligations.

InMode’s Special Committee, alongside its legal and financial advisors, intends to conduct a thorough analysis of the acquisition proposal. Their primary goal is to ascertain the potential benefits and impacts it might hold for all shareholders involved. While the committee is hoarded by a sense of duty towards the shareholders, it remains tight-lipped on any further comments regarding the proposal, signaling that discussions are still in early stages.

The Company has established itself as a leader in developing innovative medical technologies, particularly those that utilize advanced radiofrequency (RF) technology for various medical applications. InMode is recognized for producing devices that promote minimally invasive surgical procedures and enhance existing treatment offerings across numerous medical fields, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.

Reflecting on the received proposal, InMode’s unwavering focus remains on optimizing shareholder value. As the independent directors embark on reviewing the unsolicited offer, various factors will be weighed, including the credibility and resources of the proposal itself. The Special Committee's careful evaluation will determine whether the offer from Steel Partners aligns with InMode’s long-term strategic objectives and overall mission to provide cutting-edge medical solutions.

InMode also reminds its stakeholders of the inherent uncertainties present in such forward-looking corporate maneuvers. Changes in market conditions, potential competing offers, and the ever-evolving landscape of corporate acquisitions contribute to the complexity of this situation.

Through its illustrious journey, InMode has established a reputation for innovation and excellence, which positions it favorably in the face of challenges and market opportunities alike. The outcome of this proposal review process holds significant implications for InMode’s future, reflecting not just on the Company’s growth trajectory but also on its ability to adapt in an ever-evolving industry. As the situation develops, InMode remains committed to keeping its shareholders and stakeholders informed, while upholding its dedication to advancing healthcare through technology.

With the unfolding drama of the proposal and the anticipated evaluations from the Special Committee, the wider medical technology community and investors alike are keenly observing how InMode navigates this potential acquisition and what it may mean for sustainability and innovation in the sector. While specifics remain under wraps, InMode is poised to act in what it deems to be the best interests of its shareholders in the face of this unsolicited approach.